Showing results (51-60 of 97) with videos related to

Sort By:
Pageof 10
American Journal of Clinical Pathology|September 1, 1988
Comparison of "host cell infiltrates" in patients with follicular lymphoma with and without spontaneous regressionJ G Strickler, C M Copenhaver, V A Rojas, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1995
Brief chemotherapy, Stanford V, and adjuvant radiotherapy for bulky or advanced-stage Hodgkin's disease: a preliminary reportN L Bartlett, S A Rosenberg, R T Hoppe, et al.
Cancer Treatment Reports|May 1, 1987
Third-line chemotherapy for resistant Hodgkin's disease with lomustine, etoposide, and methotrexateA Tseng, C Jacobs, C N Coleman, et al.
Cancer|November 1, 1991
Clinical significance of morphologic subdivision in diffuse large cell lymphomaL W Kwak, M Wilson, L M Weiss, et al.
Cancer|November 15, 1985
Gynecomastia in testicular cancer patients. Prognostic and therapeutic implicationsA Tseng, S J Horning, F S Freiha, et al.
Blood|May 1, 1984
Clinical relevance of immunologic phenotype in diffuse large cell lymphomaS J Horning, R S Doggett, R A Warnke, et al.
The American Journal of Pathology|March 1, 1986
Clonal T-cell populations in angioimmunoblastic lymphadenopathy and angioimmunoblastic lymphadenopathy-like lymphomaL M Weiss, J G Strickler, R F Dorfman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1994
Fractionated total-body irradiation, etoposide, and cyclophosphamide plus autografting in Hodgkin's disease and non-Hodgkin's lymphomaS J Horning, R S Negrin, J C Chao, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 2000
Assessment of the stanford V regimen and consolidative radiotherapy for bulky and advanced Hodgkin's disease: Eastern Cooperative Oncology Group pilot study E1492S J Horning, J Williams, N L Bartlett, et al.
Pageof 10